On Invalid Date, Adicet Bio (NASDAQ: ACET) reported Q4 2023 earnings per share (EPS) of -$0.68, up 5.56% year over year. Total Adicet Bio earnings for the quarter were -$29.49 million. In the same quarter last year, Adicet Bio's earnings per share (EPS) was -$0.72.
As of Q2 2024, Adicet Bio's earnings has grown year over year. Adicet Bio's earnings in the past year totalled -$142.66 million.
What is ACET's earnings date?
Adicet Bio's earnings date is Invalid Date. Add ACET to your watchlist to be reminded of ACET's next earnings announcement.
What was ACET's revenue last quarter?
On Invalid Date, Adicet Bio (NASDAQ: ACET) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Adicet Bio's revenue was $0.00.
What was ACET's revenue growth in the past year?
As of Q2 2024, Adicet Bio's revenue has grown -100% year over year. This is 248.97 percentage points lower than the US Biotechnology industry revenue growth rate of 148.97%. Adicet Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.